MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 121 filers reported holding MYOVANT SCIENCES LTD in Q4 2022. The put-call ratio across all filers is 1.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,348,000 | – | 50,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 85,000 | $1,132,000 | 1.20% |
Bellevue Group AG | 5,859,039 | $78,042,000 | 0.91% |
APIS CAPITAL ADVISORS, LLC | 40,000 | $533,000 | 0.64% |
Pier Capital, LLC | 294,954 | $3,929,000 | 0.50% |
Resolute Capital Asset Partners LLC | 50,000 | $666,000 | 0.42% |
Rhenman & Partners Asset Management AB | 249,300 | $3,321,000 | 0.33% |
Hennion & Walsh Asset Management, Inc. | 409,079 | $5,449,000 | 0.29% |
TORRAY INVESTMENT PARTNERS LLC | 79,868 | $1,064,000 | 0.17% |
PLATINUM INVESTMENT MANAGEMENT LTD | 195,211 | $2,600,000 | 0.08% |
DUALITY ADVISERS, LP | 54,164 | $721,000 | 0.08% |